|04-12-2018, 02:53 PM||#1|
Join Date: Nov 2003
False Estimates of Elevated Creatinine
US National Library of Medicine
National Institutes of Health
Advanced Journal list
Journal ListPerm Jv.16(2); Spring 2012PMC3383162
Logo of permanentej
Perm J. 2012 Spring; 16(2): 51–52.
False Estimates of Elevated Creatinine
Manpreet Samra, MD and Antoine C Abcar, MD
Author information ► Copyright and License information ► Disclaimer
This article has been cited by other articles in PMC.
One of the most common reasons for a nephrology consult is an elevated creatinine. An elevation in the serum creatinine concentration usually reflects a reduction in the glomerular filtration rate (GFR). Given the association of elevated creatinine and risk of cardiovascular mortality, it is important to keep in mind that at times the elevation of the creatinine is not representative of a true reduction in GFR. There are various causes of factitious elevation of creatinine. They can be broadly grouped into increased production of creatinine, interference with the assay and decreased tubular secretion of creatinine.
A colleague asks about a patient: a woman, age 48 years, diagnosed with hypertension for 2 years and with hyperlipidemia for 10 months who has had a steadily increasing creatinine level, from 0.7 to 1.8 over the last 8 months. Her medications include hydrochlorothiazide per os 12.5 mg/day and fenofibrate per os 200 mg/day.
One of the most common reasons for nephrology consult is elevated creatinine, which usually reflects a reduction in glomerular filtration rate (GFR). Given the association of elevated creatinine with cardiovascular mortality, it is important to keep in mind that elevated creatinine is not always representative of a reduction in GFR. Here, we will discuss the various causes of false estimates of elevated creatinine.
Patients have few signs and symptoms during early renal disease. Early detection of abnormal kidney function is important, because early treatment usually slows disease progression.
Because it is not possible to directly measure kidney function or the GFR, a surrogate is needed. The endogenous marker most commonly used to measure kidney function is creatinine.1 Creatinine is generated in muscle and is proportionate to muscle mass and remains relatively constant. Eighty-five percent to 90% of creatinine is excreted by the kidney; the rest undergoes tubular secretion. It is most commonly measured by a colorimetric assay called the Jaffe reaction. In the Jaffe reaction, creatinine combines with picric acid to form a colored complex that is measured to quantify the creatinine.
With this in mind, we can discern multiple factors that may artificially increase the estimated creatinine level. These can be grouped into three categories: increased production of creatinine, interference with the assay, and decreased tubular secretion of creatinine.
Increased Creatinine Production
Creatinine is produced in muscle by the nonenzymatic conversion of creatine and phosphocreatinine. The creatinine generated is proportional to muscle mass and is relatively constant. The liver has an important role in the formation of creatinine through methylation of guanidine aminoacetic acid. The serum creatinine can vary by 0.5 to 1.0 mg/dL according to diurnal and menstrual variations, race, and diet (and method of meat preparation).
An increase in serum creatinine can result from increased ingestion of cooked meat (which contains creatinine converted from creatine by the heat from cooking) or increased intake of protein and creatine supplements, in excess of the recommended dosage. Creatine is present in the organs, muscles, and body fluids of animals. Creatine supplements promote protein synthesis and are a quickly available source of energy for muscle contraction, hence they are used to enhance athletic performance. Furthermore, intense exercise can increase creatinine by increasing muscle breakdown.2,3
Interference With the Assay
As stated earlier, the Jaffe reaction is a colorimetric assay. It can be influenced by other endogenous chromogens such as acetone and acetoacetate (such as in diabetic ketoacidosis), fasting, lipemia, and hemolysis, resulting in an overestimate of the serum creatinine. Drugs that can interfere with the assay include antibiotics such as cephalosporins, specifically cefoxitin and cefazolin; barbiturates; N-acetylcyteine; and chemotherapeutic agents such as flucytosine (although by a different assay: the Kodak Ektachem method).4,5 Another material known to interfere with the Jaffe reaction is nitromethane, a common component of radio-controlled-vehicle fuels.
The Kodak Ektachem method uses an ammonia reaction to quantify creatinine. Creatinine is converted to N-methylhydantoin and ammonia. Flucytosine is the only agent known to cause a false elevated creatinine result when this method is used.6 This artificial result is attributed to the 4-amino group of flucytosine, which is converted to free ammonia by creatine iminohydrolase.
More specific creatinine assays not subject to such interference are being investigated. One such assay, the VITROS CREA, employs an oxidation reaction to measure endogenous creatinine levels and will soon be available at laboratories within Kaiser Permanente. The VITROS CREA assay will quantify creatinine with greater precision.
Approximately 15% of creatinine is secreted in the tubules. It is secreted by the organic cation secretory pump that can be inhibited by other organic cations. Trimethoprim, cimetidine, and other H2-blockers medications can inhibit this process and cause an increase in the measured serum creatinine7,8 (Table 1).
An external file that holds a picture, illustration, etc. Object name is i1552-5775-16-2-51-t01.jpg
Common causes of false estimates of elevated creatinine
Case in Question
In the above-mentioned patient we stopped the fenofibrate, and we saw her creatinine trend toward normal in a few months. It is postulated that fibrates (particularly fenofibrate) impair the generation of vasodilatory prostaglandins and could alter intrarenal hemodynamics, possibly altering GFR, but the definitive mechanism by which this occurs is still to be elucidated.9
Case studies of renal transplant patients have shown evidence of tubular toxicity caused by fenofibrates and increased creatinine production.10 The magnitude of changes in creatininemia ranged from 8% to 18% for fenofibrate. The change in creatinine, though, has been shown to be reversible after fibrate withdrawal.
In conclusion, when elevated serum creatinine is detected, it is important to evaluate the patient as a whole to rule out possible causes.
The author(s) have no conflicts of interest to disclose.
Leslie E Parker, ELS, provided editorial assistance.
1. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985 Nov;28(5):830–8. [PubMed]
2. Hamilton RW, Gardner LB, Penn AS, Goldberg M. Acute tubular necrosis caused by exercise-induced myoglobinuria. Ann Intern Med. 1972 Jul;77(1):77–82. [PubMed]
3. Oh MS. Does serum creatinine rise faster in rhabdomyolysis? Nephron. 1993;63(3):255–7. [PubMed]
4. Molitch ME, Rodman E, Hirsch CA, Dubinsky E. Spurious serum creatinine elevations in ketoacidosis. Ann Intern Med. 1980 Aug;93(2):280–1. [PubMed]
5. Saah AJ, Koch TR, Drusano GL. Cefoxitin falsely elevates creatinine levels. JAMA. 1982 Jan 8;247(2):205–6. [PubMed]
6. Mitchell EK. Flucytosine and false elevation of serum creatinine level. Ann Intern Med. 1984 Aug;101(2):278. [PubMed]
7. Berg KJ, Gjellestad A, Nordby G, et al. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney allografted patients. Nephron. 1989;53(3):218–22. [PubMed]
8. Kemperman FA, Silberbusch J, Slaats EH, Prins AM, Krediet RT, Arisz L. Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2. Clin Nephrol. 2000 Oct;54(4):255–60. [PubMed]
9. Broeders N, Knoop C, Antoine M, Tielemans C, Abramowicz D. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Nephrol Dial Transplant. 2000 Dec;15(12):1993–9. [PubMed]
10. Angeles C, Lane BP, Miller F, Nord EP. Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity. Am J Kidney Dis. 2004 Sep;44(3):543–50. [PubMed]